Delivery Order SPE2DB24D2010-SPE2DB25FZVJ8
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,040.59 to AmerisourceBergen Drug Corp for FYCOMPA 8 mg tablets (30-count packages) on September 12, 2025, with an ultimate completion date of September 15, 2025. This is a firm fixed price delivery order with no set-aside designation, performed at the contractor's corporate office location in Conshohocken, Pennsylvania. FYCOMPA (perampanel) is a neurological medication used as an adjunctive treatment for epilepsy and seizure...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,072.56 to AmerisourceBergen Drug Corp for 30 tablets of Fycompa 6 mg on September 3, 2025, with completion scheduled for September 4, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the vendor's corporate office in Conshohocken, Pennsylvania. Fycompa is an antiepileptic medication used to treat partial-onset seizures, reflecting AmerisourceBergen's role...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of FYCOMPA 12 mg tablets (30-count units) under a firm fixed-price contract with a ceiling value of $2,152.34. This is a competitively awarded, non-set-aside delivery order with an ultimate completion date of August 1, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $7,307.89 to AmerisourceBergen Drug Corp for Fycompa 0.5 mg/ml oral suspension (340ml) on July 18, 2025. This is a firm fixed price delivery order with an ultimate completion date of July 21, 2025, with performance to occur at the contractor's location in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,049.88 to AmerisourceBergen Drug Corp for FYCOMPA (perampanel) 10 mg tablets in a quantity of 30 units. This is a firm fixed price delivery order with no set-aside designation, issued on August 21, 2025, with an ultimate completion date of August 22, 2025. The pharmaceutical product will be supplied from AmerisourceBergen's location in Conshohocken, Pennsylvania. FYCOMPA is an oral anticonvulsant medication used as adjunctive...
- The Defense Logistics Agency awarded a $1,604.28 firm fixed price delivery order to AmerisourceBergen Drug Corp for FYCOMPA 8 mg tablets (30-count units) on August 13, 2025, with an ultimate completion date of August 14, 2025. This competitive award, which carries no set-aside designation, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through December 2026. The place of...
- The U.S. Defense Department's Medical Supply Chain awarded a $1,965.36 delivery order to AmerisourceBergen Drug Corp for FYCOMPA 2 mg tablets (30-count units) on May 30, 2025, with a completion date of June 2, 2025. This firm fixed-price delivery order represents a non-competitive, non-set-aside award and is performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 3, 2025, for Fycompa 8 mg tablets (30-count units) with a ceiling value of $1,713.96. This firm fixed-price delivery order, which is expected to be completed by June 4, 2025, represents a continuation of AmerisourceBergen's significant role as a pharmaceutical supplier to the federal government. The award was made without a set-aside designation, indicating open competition. The performance location is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Fycompa 0.5 mg/mL oral suspension in a 340 mL quantity, with a contract value of $2,903.46. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award through open competition. The place of performance is listed as Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters. This delivery order is executed...
- The Defense Logistics Agency awarded a delivery order valued at $2,111.20 to AmerisourceBergen Drug Corp for the supply of Fycompa 4 mg tablets (30-count units) on July 10, 2025, with completion scheduled for July 11, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and was performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement,...
- SPE2DB24D2010Indefinite Delivery Contract
- SPE2DB24D2010-SPE2DB25FZVJ8Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on February 13, 2025, for the supply of Fycompa 4 mg tablets (30-count units) with a ceiling value of $1,837.44. This firm fixed-price delivery order, which is expected to be completed by February 14, 2025, represents a non-competitive set-aside award and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Fycompa (perampanel) is an oral anticonvulsant medication used in the treatment of seizure disorders and epilepsy. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a total value of $999,999,999 and extends through December 2026. This prime pharmaceutical vendor contract serves as a comprehensive global medical supply vehicle enabling AmerisourceBergen to distribute a wide range of brand-name and generic pharmaceuticals, vaccines, and medical supplies to support military healthcare systems and the Defense Health Agency. The company's extensive portfolio of federal contract awards demonstrates its established capability as a critical pharmaceutical distributor for federal medical procurement needs across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 2/13/25 |